DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome Management
Explore the latest findings presented at ERA 2025 in Vienna, Austria, through concise video briefs, where leading experts analyze cutting-edge clinical trial data on emerging nonsteroidal mineralocorticoid receptor antagonist therapy in patients with CKD, T2D, and heart failure.
5
1-5 of 5
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Amy Mottl, MD, MPH
Muthiah Vaduganathan, MD, MPH
DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome ManagementImpact of Finerenone on eGFR Slope by Baseline Albuminuria in FINEARTS-HF
Finnian R. McCausland, MD
- DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome Management
Albuminuria Change and Finerenone's Effect on CV Outcomes
Finnian R. McCausland, MD
- DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome Management
Topline Results of the CONFIDENCE Trial
Rajiv Agarwal, MBBS, MD, FASN, BRCU
- DataPulse: Key Clinical Trial Insights on Nonsteroidal MRAs in CKM Syndrome Management
The CONFIDENCE Trial: Data Insights
prof. Hiddo Heerspink